Olon Group, a global pharmaceutical CDMO, appointed Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP ...

QRS Holdings has chosen to grow its Newark, Delaware, headquarters with a $16.6 million laboratory and office expansion.

Merck KGaA, Darmstadt, Germany, a science and technology company, has entered into a definitive agreement to acquire ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Biohaven will receive up to $600 million to support ongoing clinical trials and the full development of its portfolio.

Single Use Support, a provider of advanced fluid management and cold chain solutions for the biopharmaceutical industry, has ...

Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.

Debiopharm and Oncodesign Services have signed a license agreement for the use of Debiopharm’s AbYlink technology for ...

CN Bio, which offers Organ-on-a-chip systems, has formed a strategic partnership with Pharmaron, a life sciences R&D service ...

PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...

Mosaic Therapeutics Ltd, a targeted oncology therapeutics company dedicated to resolving cancer’s complexity with new ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...